S. Murray Sherman to Tumor Burden
This is a "connection" page, showing publications S. Murray Sherman has written about Tumor Burden.
Connection Strength
0.040
-
Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial. Cancer. 2022 06 15; 128(12):2281-2287.
Score: 0.040